Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
8.26
+0.21 (2.61%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Zevra Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Oct '24 Oct 29, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 435 | 272 | 158 | 308 | 48 | 13 | |
Market Cap Growth | 18.68% | 71.57% | -48.52% | 536.60% | 283.47% | -73.24% | |
Enterprise Value | 445 | 233 | 97 | 178 | 112 | 86 | |
Last Close Price | 8.26 | 6.55 | 4.59 | 8.71 | 11.20 | 6.07 | |
PE Ratio | - | -5.04 | -5.91 | -4.12 | -3.49 | -0.46 | |
PS Ratio | 13.70 | 9.90 | 15.59 | 10.74 | 3.64 | 0.98 | |
PB Ratio | 10.68 | 4.39 | 2.11 | 2.42 | -0.73 | -0.17 | |
P/FCF Ratio | -3.64 | -8.03 | -8.42 | 29.76 | -24.51 | -0.53 | |
P/OCF Ratio | -3.66 | -8.10 | -8.46 | 29.47 | -24.92 | -0.53 | |
EV/Sales Ratio | 18.78 | 8.49 | 9.52 | 6.21 | 8.43 | 6.71 | |
EV/EBITDA Ratio | -2.78 | -4.80 | -4.04 | 22.27 | -24.84 | -4.30 | |
EV/EBIT Ratio | -2.63 | -4.70 | -3.88 | 23.01 | -23.42 | -4.24 | |
EV/FCF Ratio | -3.49 | -6.89 | -5.14 | 17.20 | -56.79 | -3.63 | |
Debt / Equity Ratio | 1.83 | 0.71 | 0.19 | 0.01 | -1.06 | -1.07 | |
Debt / EBITDA Ratio | - | - | - | 0.18 | - | - | |
Debt / FCF Ratio | -1.06 | -1.29 | -0.75 | 0.16 | -35.77 | -3.36 | |
Asset Turnover | 0.19 | 0.19 | 0.08 | 0.40 | 1.22 | 0.69 | |
Quick Ratio | 1.91 | 1.15 | 7.58 | 26.92 | 0.90 | 0.94 | |
Current Ratio | 2.00 | 1.18 | 7.72 | 27.20 | 1.11 | 1.28 | |
Return on Equity (ROE) | -132.32% | -67.23% | -26.48% | -28.18% | - | - | |
Return on Assets (ROA) | -37.41% | -21.55% | -12.54% | 6.70% | -27.52% | -68.24% | |
Return on Capital (ROIC) | -53.66% | -31.82% | -14.28% | 7.27% | -62.18% | -121.30% | |
Earnings Yield | -15.37% | -16.95% | -16.90% | -2.78% | -26.40% | -194.59% | |
FCF Yield | -12.95% | -12.45% | -11.88% | 3.36% | -4.08% | -188.57% | |
Buyback Yield / Dilution | -14.39% | -2.79% | -15.87% | -647.71% | -114.79% | -65.39% | |
Total Shareholder Return | -14.39% | -2.79% | -15.87% | -647.71% | -114.79% | -65.39% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.